Inhaltsseite: Home

ZKB Barrier Reverse Convertible mit bedingtem Coupon on worst of
Novo Nordisk A/S/Roche Holding AG/Teva Pharmaceutical Industries Ltd

ISIN: CH1446517810 Security: 144651781 Symbol: Z0B8QZ Life cycle
gray-market

Bid Price 99.67%

Ask Price 100.47%

Currency qUSD

Exchange ZKB

Volume 250'000.00

Volume 250'000.00

Date/time (realtime) 19.06.2025 09:38:16

Sell Buy 

Underlying value

UnderlyingPriceInitial fixingCurr.Call levelDistance to call levelBarrierDistance to barrier
Novo Nordisk ADR B74.0174.34USD70.623 (95.00%)0.32%43.861 (59.00%)41.19%
Roche GS256.5261.60CHF248.520 (95.00%)-0.93%154.344 (59.00%)40.45%
Teva Pharma ind A17.0616.89USD16.046 (95.00%)1.11%9.965 (59.00%)41.66%

Reference data

ISIN CH1446517810
Security 144651781
Symbol Z0B8QZ
Currency qUSD
Currency hedging Yes
Nominal amount 1'000.00
Barrier observation at maturity

Coupon

Coupon (Coupon p.a.)5.03%
Coupon paymentbedingt
Memory effectNein
Coupon Level75.00%

Life cycle

Issue price100.00%
Initial fixing date17.06.2025
Payment day24.06.2025
First trading day24.06.2025
Last trading day17.06.2027
Final fixing day17.06.2027
Redemption date24.06.2027
Redemption typeCash Settlement
Early redemptionYes
Next observation date17.09.2025
Residual term727
Issue amount600'000.00

Price data

Price status flat Marchzins
Exchange ZKB
Trade time 09:15 - 17:15 (CET)
Round lot USD 1'000.00
Performance of underlying since issue -0.92%

Product type

SSPA derivative category Yield enhancement
SSPA code Express certificate (1260)

Legal parties

Issuer Zuercher Kantonalbank Finance (Guernsey) Ltd
Keep-Well Agreement with Zürcher Kantonalbank, Zürich
Issuer rating
Lead manager Zürcher Kantonalbank, Zürich
Payment, execution and calculation agent Zürcher Kantonalbank, Zürich

Tax aspects (Private investor tax domicile Switzerland)

Income taxYes
Withholding taxNo
Stamp duty payable in the secondary marketYes
Stamp duty payable upon delivery of the securitiesNo
SIX Telekurs EU tax classification code (out of scope)
Internal Rate of Return3.75%
Cash value of fixed income investment upon issue92.90%
Cash value of fixed income investment upon redemption100.00%

Sales restrictions

USA, US persons, Guernsey, EEA, GB

Redemption

Redemption date24.06.2027
Redemption amount
Redemption currencyn.a.
Underlyingn.a.
Physical delivery-

Ajax loading